Your browser doesn't support javascript.
loading
Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA).
Caputo, Mariela; Cerrone, Gloria Edith; López, Ariel Pablo; Villalba, Anabel; Krochik, Gabriela Andrea; Cédola, Federico Norberto; Targovnik, Héctor Manuel; Frechtel, Gustavo Daniel.
Afiliação
  • Caputo M; Laboratory of Molecular Biology, Department of Genetic and Molecular Biology, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Autoimmunity ; 38(4): 277-81, 2005 Jun.
Article em En | MEDLINE | ID: mdl-16206510
ABSTRACT
Autoimmune diabetes is an organ specific and multifactorial disorder with a classical onset as insulin dependent diabetes mellitus (IDDM) and with another form of onset as latent autoimmune diabetes in adults (LADA), which has a slower onset and a later progress to insulin dependency as a result of the beta cells destruction. The cytotoxic T lymphocyte-antigen 4 (CTLA4) has been identified as a susceptible marker of the disease; it is considered a down regulator of T cell function, playing a key role in autoimmunity. We analyzed CTLA4 codon 49 A/G polymorphism in 123 IDDM patients, 63 LADA patients and 168 healthy non-diabetic control individuals. The frequency of the heterozygous A/G genotype in LADA patients was significantly increased compared to IDDM patients (55.6 vs. 39.8%, p = 0.0415). There was no statistical significant difference in the distribution of the A/G dimorphism between autoimmune diabetes patients (LADA or IDDM) and non-diabetic control individuals. HLA DQ region is responsible for the genetic susceptibility to autoimmune diabetes in IDDM patients in about 50% and it has a lower effect in genetic susceptibility in LADA patients. Several other genetic loci are needed to develop autoimmune diabetes in adult patients. Therefore, LADA may be the result of a combined minor risk loci effect in a major risk haplotype.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígenos de Diferenciação / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígenos de Diferenciação / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2005 Tipo de documento: Article